[Gd@c82(OH)22]n nanoparticles inhibit the migration and adhesion of glioblastoma cells

Oncology Letters

Volumn 1, Issue 4, 2010, Pages 771-775

  Wang, Jing ^a   Gu, Feng ^a   Ding, Ting ^a   Liu, Xiaoli ^b   Xing, Gengmei ^b   Zhao, Yuliang ^b   Zhang, Ning ^a   Ma, Yongjie ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

Adhesion; Glioblastoma; Migration; Nanoparticle GD@C82(OH)22 n

Indexed keywords

FULLERENE; NANOPARTICLE;

ARTICLE; CELL ADHESION; CELL LEVEL; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; TUMOR CELL;

EID: 77954925920     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000135     Document Type: Article

References (22)

1. Kroto HW, Heath JR, O'Brien SC, Curl RF and Smalley RE: C60: Buckminsterfullerene. Nature 318: 162-163, 1985.
2. Wang J, Chen C, Li B, et al: Antioxidative function and biodis-tribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice. Biochem Pharmacol 71: 872-881, 2006.
3. Cagle DW, Kennel SJ, Mirzadeh S, Alford JM and Wilson LJ: In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc Natl Acad Sci USA 96: 5182-5187, 1999.
4. Chen C, Xing G, Wang J, et al: Multihydroxylated [Gd@ C82(OH)22]n nanoparticles: antineoplastic activity of high eff-ciency and low toxicity. Nano Lett 5: 2050-2057, 2005.
5. Anderson SA, Lee KK and Frank JA: Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol 41: 332-338, 2006.
6. Mikawa M, Kato H, Okumura M, et al: Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug Chem 12: 510-514, 2001.
7. Bolskar RD, Benedetto AF, Husebo LO, et al: First soluble M@ C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J Am Chem Soc 125: 5471-5478, 2003.
8. Zhang B, Gu F, She C, et al: Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125: 585-595, 2009.
9. Guo H, Gu F, Li W, et al: Reduction of protein kinase c zeta inhibits migration and invasion of human glioblastoma cells. J Neurochem 109: 203-213, 2009.
10. Huang J, Chen K, Gong W, Dunlop NM and Wang JM: G-protein coupled chemoattractant receptors and cancer. Front Biosci 13: 3352-3363, 2008.
11. Kurosaka S and Kashina A: Cell biology of embryonic migration. Birth Defects Res C Embryo Today 84: 102-122, 2008.
12. Rorth P: Collective cell migration. Annu Rev Cell Dev Biol 25: 407-429, 2009.
13. Etienne-Manneville S and Hall A: Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106: 489-498, 2001.
14. Lefranc F, Brotchi J and Kiss R: Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-2422, 2005.
15. Wischhusen J, Schneider D, Mittelbronn M, et al: Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system. J Neuroimmunol 162: 28-42, 2005.
16. Li H and Nord EP: CD40/CD154 ligation induces mononuclear cell adhesion to human renal proximal tubule cells via increased ICAM-1 expression. Am J Physiol Renal Physiol 289: F145-F153, 2005.
17. Sumimoto S and Mayumi M: [Role of LFA-1/ICAM-1-dependent cell adhesion in CD40-mediated inhibition of anti-IgM antibody-induced B-cell death]. Nippon Rinsho 54: 1779-1783, 1996.
18. Jain KK: Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta 358: 37-54, 2005.
19. Juillerat-Jeanneret L and Schmitt F: Chemical modifcation of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail. Med Res Rev 27: 574-590, 2007.
20. LaRocque J, Bharali DJ and Mousa SA: Cancer detection and treatment: the role of nanomedicines. Mol Biotechnol 42: 358-366, 2009.
21. Yin JJ, Lao F, Meng J, et al: Inhibition of tumor growth by endo-hedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol 74: 1132-1140, 2008.
22. Roebuck KA and Finnegan A: Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66: 876-888, 1999.